Development and routine implementation of deep learning algorithm for automatic brain metastases segmentation on MRI

Loïse Dessoude1, Raphaëlle Lemaire2, Romain Andres2

  • 1Radiotherapy Department, Centre François Baclesse, Caen 14000, France.

Neuroimage
|January 12, 2025
PubMed
Abstract

Insights

This study introduces an AI solution for segmenting brain metastases (BM) on MRI, accurately assessing RANO-BM criteria and lesion volume. The accessible tool saves time and improves clinical trial monitoring for brain metastases.

Area of Science:

  • Radiology and Medical Imaging
  • Artificial Intelligence in Medicine
  • Oncology

Background:

  • Current RANO-BM criteria for brain metastases (BM) assessment are time-consuming and imperfect due to lesion heterogeneity.
  • Clinical trials rarely achieve full compliance with RANO-BM criteria in routine practice.
  • Accurate and efficient monitoring of BM is crucial for patient management and clinical trial success.

Purpose of the Study:

  • To develop and validate an AI solution for delineating brain metastases (BM) on MRI.
  • To enable easy and routine acquisition of RANO-BM criteria and BM volume using an in-house AI tool.
  • To overcome the limitations of manual RANO-BM assessment in clinical settings.

Main Methods:

  • A deep learning (DL) model utilizing the UNETR transfer learning method was developed.
  • The model was trained and validated on 27,456 post-Gadolinium-T1 MRI scans from 132 patients with BM.
  • PyTorch and PyTorch Lightning frameworks were used for model construction.

Main Results:

  • The AI model achieved 100% accuracy in predicting RANO-BM criteria compared to expert assessment.
  • A high overlap between AI and expert segmentation was observed, with a mean DICE score of 0.77.
  • AI-derived diameter and volume measurements of BM lesions were concordant with reference segmentations.

Conclusions:

  • The developed in-house deep learning solution provides effective BM segmentation and RANO-BM criteria assessment.
  • The AI tool offers substantial time savings and is accessible without AI expertise.
  • This solution facilitates routine clinical application and improves monitoring of brain metastases.

Related Concept Videos